| Description | Obrindatamab, a humanized anti-B7-H3/CD3 bispecific antibody, targets B7-H3 and CD3, facilitating redirected cytotoxic T-lymphocyte (CTL) activity towards B7-H3-expressing cancer cells. It is utilized in cancer research [1]. |
| molecular weight | N/A |
| CAS | 2069959-72-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |